Table_1_Effect of omalizumab on inflammatory markers in COVID-19: an exploratory analysis of the COVID-19 immunologic antiviral therapy with omalizumab (CIAO) trial.docx

Table_1_Effect of omalizumab on inflammatory markers in COVID-19: an exploratory analysis of the COVID-19 immunologic antiviral therapy with omalizumab (CIAO) trial.docx

Background<p>The CIAO trial recently demonstrated a probable clinical benefit of omalizumab in the treatment of severe COVID-19; however, the mechanism underlying this benefit remains unclear. Therefore, we sought to longitudinally assess the impact of omalizumab on serum cytokines in CIAO tri...

وصف كامل

محفوظ في:
التفاصيل البيبلوغرافية
المؤلف الرئيسي: Connor Prosty (13014441) (author)
مؤلفون آخرون: Michelle Le (3826864) (author), Yang Lu (59885) (author), Lauren Khoury (16900620) (author), Maxime Cormier (2697130) (author), Mathew P. Cheng (20286738) (author), Robert Fowler (662365) (author), Srinivas Murthy (188776) (author), Jennifer LY Tsang (2621734) (author), Duncan Lejtenyi (20286741) (author), Moshe Ben-Shoshan (4379185) (author), Elham Rahme (261544) (author), Shirin Golchi (13771192) (author), Nandini Dendukuri (118407) (author), Todd C. Lee (4030973) (author), Elena Netchiporouk (6599024) (author)
منشور في: 2024
الموضوعات:
Dermatology
Emergency Medicine
Gastroenterology and Hepatology
Geriatrics and Gerontology
Intensive Care
Medical Genetics (excl. Cancer Genetics)
Nephrology and Urology
Nuclear Medicine
Orthopaedics
Otorhinolaryngology
Pathology (excl. Oral Pathology)
Radiology and Organ Imaging
Foetal Development and Medicine
Obstetrics and Gynaecology
Family Care
Primary Health Care
Medical and Health Sciences not elsewhere classified
omalizumab
coronavirus
COVID-19
clinical trial
cytokine
الوسوم: إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!

مواد مشابهة

مواد مشابهة